Ad copy

#Sponsored by @VEOZAH (fezolinetant). Swipe for Important Safety Information, including BOXED WARNING. For U.S. audiences only. Women experiencing moderate to severe hot flashes due to menopause are not alone – nearly half of menopausal women may experience them. VEOZAH is the #1 prescribed first-of-its-kind hormone-free, FDA-approved prescription treatment for moderate to severe hot flashes due to menopause.* VEOZAH blocks the binding of NKB, a brain chemical known to trigger hot flashes during menopause. VEOZAH can cause serious side effects, including liver problems. A healthcare provider will do a blood test to check liver function before treatment with VEOZAH begins. A healthcare provider will also do this blood test monthly for the first 3 months, at month 6, and month 9 after treatment begins or if there are signs or symptoms that suggest liver problems. If liver blood test values are elevated, a healthcare provider may advise stopping treatment or request additional liver blood tests. Stop VEOZAH right away and call a healthcare provider if signs or symptoms of liver problems occur, such as feeling more tired than usual, decreased appetite, nausea, vomiting, itching, yellowing of the eyes or skin (jaundice), pale feces, dark urine, or pain in the stomach (abdomen). Please visit @veozah_ppi to see Patient Information, including BOXED WARNING. *IQVIA TRx data from May 2023 to December 5, 2025.